Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individually Adapted Therapy of Alcoholism
NCT00317031Phase 4Completed
- Sponsor
- Central Institute of Mental Health
- Start
- Nov 2002
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acamprosate, naltrexone in alcohol use disorder (AUD), sponsored by Central Institute of Mental Health. Started Nov 2002; status: completed.
02
Drugs
acamprosatenaltrexone
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT00317031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00317031.